Mymetics Corp. is a biotechnology company, which engages in the research and development of virosome based vaccines. It focuses on next generation vaccines for infectious and life disabling diseases. The company was founded in July 1994 and is headquartered in Epalinges, Switzerland.
Company profile
Ticker
MYMX
Exchange
Website
CEO
Ronald Hugo Gerard Kempers
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
ICHOR CORP, PDG REMEDIATION INC
SEC CIK
Corporate docs
IRS number
251741849
MYMX stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
2 Jan 24
8-K
Amendments to Articles of Incorporation or Bylaws
28 Dec 23
EFFECT
Notice of effectiveness
13 Dec 23
POS AM
Prospectus update (post-effective amendment)
8 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Dec 23
POS AM
Prospectus update (post-effective amendment)
8 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Dec 23
10-Q
2023 Q3
Quarterly report
20 Nov 23
NT 10-Q
Notice of late quarterly filing
15 Nov 23
DEF 14C
Information statement
27 Oct 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 62.00 k | 62.00 k | 62.00 k | 62.00 k | 62.00 k | 62.00 k |
Cash burn (monthly) | 113.33 k | 28.25 k | 371.33 k | 963.92 k | 111.67 k | 144.83 k |
Cash used (since last report) | 774.34 k | 193.02 k | 2.54 mm | 6.59 mm | 762.95 k | 989.56 k |
Cash remaining | -712.34 k | -131.02 k | -2.48 mm | -6.52 mm | -700.95 k | -927.56 k |
Runway (months of cash) | -6.3 | -4.6 | -6.7 | -6.8 | -6.3 | -6.4 |